The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparative effectiveness of carboplatin-pemetrexed (Carbo-Pem) with vs. without bevacizumab (Bev) in patients with advanced non-squamous (Sq) non-small cell lung cancer (NSCLC).
 
Stephen Joseph Bagley
Research Funding - Incyte; Novocure
 
Nandita Mitra
No Relationships to Disclose
 
Neal J. Meropol
Employment - Flatiron Health
Research Funding - Genomic Health
Patents, Royalties, Other Intellectual Property - US Patent (20020031515): Methods of therapy for cancers characterized by over expression of the HER2 receptor protein; US Patent Office “Systems and methods for matching patients with clinical trials.” (Cui, Mergler, Meropol, Tao, and Guo-Qiang Zhang). Patent pending, filed January 5, 2016. 14/988,132
Travel, Accommodations, Expenses - Flatiron Health
 
Benjamin Holzman
Employment - Flatiron Health
Stock and Other Ownership Interests - Flatiron Health
 
Roger B. Cohen
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Cerulean Pharma; Heat Biologics; Kolltan Pharmaceuticals; Pfizer; Takeda; Zymeworks
Research Funding - Celldex (Inst); Cleave Biosciences (Inst); Heat Biologics (Inst); Macrogenics (Inst); Merck (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Cerulean Pharma; Heat Biologics; Kolltan Pharmaceuticals; Pfizer; Takeda; Zymeworks
 
Corey J. Langer
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Abbott Biotherapeutics; ARIAD; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; Cancer Support Community; Celgene; Clarient; Clovis Oncology; Genentech/Roche; Lilly/ImClone; Merck; Takeda
Research Funding - Advantagene (Inst); Ariad (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Inovio Pharmaceuticals (Inst); Merck (Inst); Stem CentRx (Inst)
Other Relationship - Amgen; Lilly; Peregrine Pharmaceuticals; Synta
 
Anil Vachani
Consulting or Advisory Role - Abbvie; OncoCyte
Research Funding - Integrated Diagnostics; MagArray; Transgenomic